MLYS Mineralys Therapeutics, Inc.
$21.13▲ +2.77%
Healthcare
Other
Volume 3.20M
Avg Volume (10D) 1.24M
Key Metrics & Fundamentals
Market Cap
$1.87B
P/E Ratio
–
Div Yield
0.00%
52W Range
20.12 - 47.65
% vs 50 MA
-15.97%
% vs 200 MA
-22.27%
RSI-14
40.4
MACD Histogram
+0.0800
Beta (1Y vs SPY)
1.35
Free Cash Flow
-$32.56M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$246.04M
COGS
–
Operating Exp
$246.04M
Operating Income
-$246.04M
EBIT
-$246.04M
Pretax Income
-$241.07M
Net Income
-$241.07M
EPS (Diluted)
-2.85
Price & Volume History
Loading chart…
Recent News
Mineralys Therapeutics Presents New Lorundrostat Data in Participants with Hypertension and Chronic Kidney Disease at ASN Kidney Week 2026
GlobeNewswire · Oct 22, 2026 6:40 PM ET
Mineralys Therapeutics Expands its Board of Directors with the Appointments of Kristine Peterson and Lonnel Coats
GlobeNewswire · Oct 19, 2026 4:05 PM ET
Mineralys Therapeutics (MLYS) Shares New Lorundrostat Data, Is The Stock A Bargain?
Simply Wall St. · Oct 12, 2026 7:26 PM ET
Mineralys Therapeutics Presents New Data for Lorundrostat at the American Heart Association Hypertension Scientific Sessions 2026
GlobeNewswire · Oct 9, 2026 9:00 AM ET
Mineralys Therapeutics Announces Presentation of New Lorundrostat Data at the American Society of Nephrology (ASN) Kidney Week 2026
GlobeNewswire · Oct 2, 2026 4:30 PM ET
Mineralys Therapeutics Announces Presentation of Lorundrostat Data at American Heart Association Hypertension Scientific Sessions 2026
GlobeNewswire · Oct 1, 2026 4:05 PM ET
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Sep 29, 2026 4:05 PM ET
Mineralys Therapeutics (MLYS) Faces A Fresh Valuation Test On New Lorundrostat Data
Simply Wall St. · Sep 28, 2026 1:08 PM ET
Mineralys Therapeutics to Participate in the Stifel 2026 Virtual Cardiometabolic Forum
GlobeNewswire · Sep 24, 2026 4:05 PM ET
Mineralys Therapeutics’ Transform-HTN Open-Label Extension Trial Data Selected for Late-Breaking Presentation at American Heart Association Scientific Sessions 2026
GlobeNewswire · Sep 23, 2026 4:05 PM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See MLYS's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.